At the end of the day, if SLA management don't give any pricing details as to what the Russians will be paying per course, the June finance figures will demonstrate just how much this product will generate in revenues. Expect at least three months of ropren selling in this particular period so the mathematical gurus here should be able to deduce from the June quarter figures if not the exact amount being paid for ropren, at least a roundabout figure. The RM research paper gives some projections as to how huge this company could/will be and recent figures given for outside of Russia for ropren IMO give a clear indication that the $1000 amount is way out of the ball game.
SLA Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)